D, M., D, C., B, C., P, K., & TC, B. (2021). A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease. Dove Medical Press.
Style de citation Chicago (17e éd.)D, McMullin, Clark D, Cavanagh B, Karpecki P, et Brady TC. A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)D, McMullin, et al. A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.